Startup profile for QuantrolOx: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

QuantrolOx funding, valuation and investors

Oxford quantum-computing control software specialist automating qubit tuning.

Verified company research · funding, investors and latest developments

Keep track of QuantrolOx

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Financing (stage not independently verified)

€12M · October 22, 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

Stage not recorded · Oxford, UK

Investors in latest funding

Lead: IW Capital

Other: European Innovation Council Fund

Sources: latest funding · news.sky.com Last verified: 2026-10-26

Overview

QuantrolOx is an Oxford University spinout developing machine-learning tools for automated tuning, calibration and control of quantum processors. Sky News reported on October 22, 2026 that it secured a €12 million fundraising led by IW Capital with participation from the European Innovation Council Fund. Commercial adoption and financial terms beyond the announced amount have not been independently verified.

Why QuantrolOx is interesting

Its control layer is relevant across competing quantum processor architectures, unlike companies betting on one qubit modality.

Funding history (newest first)

Financing (stage not independently verified)

2026-10-22 €12M
  • IW Capital (lead)
  • European Innovation Council Fund (participant)

Source: Read source · news.sky.com

Industries

Market / IPO context

Editorial / static context — not a live quote.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.